|Awarded On||August 24, 2018|
|Title||GCC Center for Comprehensive PK/PD and Formulation|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||Texas Southern University|
|Principal Investigator/Program Director||Dong Liang|
|Cancer Sites||All Sites|
Cancer research is evolving rapidly, with many new potential therapeutics reported regularly. However, many of cancer researchers do not have the resources necessary to even begin the FDA's lengthy and costly drug approval process. One of the key challenges for academic cancer researchers and small biotech companies is limited-to-no access to specialized drug development expertise and facilities available to large drug companies. While there are a few Texas core facilities available for discovery of new potential drugs, the next crucial step is to test how the body affects the drug (pharmacokinetics; PK) and how the drug affects the body (pharmacodynamics; PD). Additionally, it is very imp...